Delivery Order SPE2DB22D3301-SPE2DB25FZ0UJ
- Not listed
- The Defense Logistics Agency awarded a $3,196.76 delivery order to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100 count) with an ultimate completion date of August 20, 2025. This non-competitive delivery order represents a firm fixed price purchase executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The vendor, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency (DLA) awarded a $3,194.98 delivery order to AmerisourceBergen Drug Corp for the supply of Clobazam 10 mg tablets (100 count) under a firm fixed-price contract type. The award, made on September 4, 2025, with an ultimate completion date of September 5, 2025, is not designated as a set-aside contract and represents a competitively awarded transaction. Performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,626.48 to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100 count) on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100-count) valued at $1,555.93 under a firm fixed price contract. The award was made on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-competitive delivery against an existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location in the same city. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,180.96 delivery order for 100 tablets of Clobazam 10 mg, with an ultimate completion date of August 1, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving critical federal medical procurement needs, particularly for military and veteran healthcare systems. The award...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,622.52 on August 14, 2025, for the supply of Clobazam 10 mg tablets (100 count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 15, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Clobazam 10 mg tablets (100-count) valued at $2,214.14. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and requires completion by September 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a leading pharmaceutical...
- The Defense Logistics Agency awarded a $5,030.27 firm fixed price delivery order to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This non-set-aside contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,667.79 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Clobazam 10 mg tablets (100 count) valued at $10,427.89 under a firm fixed price contract. The award, issued on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a non-set-aside competitively awarded delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery at its...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0UJDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,223.72 to AmerisourceBergen Drug Corp for the supply of Clobazam 10 mg tablets (100-count) on September 10, 2025, with completion targeted for September 11, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order supports the Defense Logistics Agency's Medical Supply Chain by sourcing a specialty neurological medication for military and veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, regularly fulfills federal pharmaceutical procurement needs across multiple therapeutic domains, including neurological treatments, diabetes medications, pain management products, and specialized medical supplies. The contract exemplifies the company's role as a critical vendor within DLA's pharmaceutical distribution network, leveraging the comprehensive SPE2DX prime vendor agreement to provide time-sensitive medical commodities to support military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 9/10/25 |